RESPIRATORY TRACT DISEASES

This study looks at how well the RSV vaccine (ABRYSVO) given during pregnancy prevents serious RSV lung infections in babies. Researchers will review health records of infants up to 12 months old who were hospitalized with breathing problems. They will compare RSV test results to…

This study looks at how effective the ABRYSVO® vaccine is when given to pregnant women to protect their babies from RSV, a serious respiratory virus. Researchers will review medical records of infants up to 9 months old who were hospitalized with breathing problems. The goal is t…

This program offers taletrectinib to adults with advanced or spreading ROS1-positive non-small cell lung cancer who cannot use approved treatments or join ongoing studies. Participants must have a ROS1 gene fusion and adequate organ function. The goal is to provide potential bene…

This study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutated non-small cell lung cancer. About 532 adults with stage IIIB, IIIC, or IV lung cancer that cannot be surgically removed are being observ…

This study tests if the drug bevacizumab can help adults with a rare condition called recurrent respiratory papillomatosis (RRP), which causes wart-like growths in the airways that often need repeated surgeries. About 21 participants will receive the drug through an IV after surg…

This study tests a new device called the Aventus Thrombectomy System to safely remove blood clots from the lungs in people with a sudden, severe pulmonary embolism. About 130 adults aged 18 to 80 with symptoms lasting less than two weeks will be enrolled. The goal is to see if th…

This study looks at whether educating doctors in smaller city and county hospitals can improve how they test and treat patients with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more patients get the right molecular tests and targeted therap…